Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities

J Psychoactive Drugs. 2010 Sep:Suppl 6:227-38. doi: 10.1080/02791072.2010.10400546.

Abstract

Research has confirmed the effectiveness of medications, when used in conjunction with ongoing counseling, to treat substance abuse disorders. This article describes a national, mixed-methods research project designed to investigate single state authorities' (SSAs) perceptions of adoption of evidence-based practices in substance abuse treatment. Results are focused specifically on medication-assisted treatment, one of five evidence-based practices defined by the National Quality Forum. Medication-assisted treatment (MAT) is an important and effective part of comprehensive care options available to clients who are chronically ill with alcohol and other drug disorders. Despite mounting clinical evidence and increased availability, overall rates of implementation and sustained adoption of medications to treat addiction remain limited. The results illustrate that the SSA representatives who fund public treatment programs believe MAT is a priority and worthy of system-wide implementation. Current strategies utilized by SSAs to support the adoption of MAT are detailed, as are barriers to adoption and implementation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Evidence-Based Practice*
  • Health Plan Implementation
  • Humans
  • Substance Abuse Treatment Centers / standards
  • Substance-Related Disorders / therapy*